Welcome to LookChem.com Sign In|Join Free

CAS

  • or

73-24-5

Post Buying Request

73-24-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

73-24-5 Usage

Chemical Description

Adenine is a purine base found in DNA and RNA.

Description

adenine is one of the purine nitrogenous bases that composes DNA and RNA; composed of two carbon–nitrogen rings. Adenine bonds with thymine in DNA and with uracil in RNA (see base pairing rule); it is also a major component of other molecules such as adenosine triphosphate.

Chemical Properties

Adenine is a prominent member of the family of naturally occurring purines. Adenine occurs not only in ribonucleic acids (RNA), and deoxyribonucleic acids (DNA), but in nucleosides, such as adenosine, and nucleotides, such as adenylic acid, which may be linked with enzymatic functions quite apart from nucleic acids. Adenine, in the form of its ribonucleotide, is produced in mammals and fowls endogenously from smaller molecules and no nutritional essentiality is ascribed to it. In the nucleosides, nucleotides, and nucleic acids, the attachment or the sugar moiety is at position 9.The purines and pyrimidines absorb ultraviolet light readily, with absorption peaks at characteristic frequencies. This has aided in their identification and quantitative determination.

Physical properties

Adenine is a white to almost white crystalline powder that is an important biological compound found in deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and adenosine triphosphate (ATP). It was once commonly referred to as vitamin B4 but is no longer considered a vitamin. Adenine is derived from purine. Purine is a heterocyclic compound.

History

Adenine is one of the two purines found in DNA and RNA. The other is guanine. Adenine and guanine are called bases in reference to DNA and RNA. A nucleic acid base attached to ribose forms a ribonucleoside. Adenine combined with ribose produces the nucleoside adenosine.

Uses

Adenine is used as an active component of boron-deficient media to grow yeast in order to assess whether yeast growth is stimulated by boron. It is useful as a local antiseptic and vitamin B4. Further, it is used in the microbial determination of niacin. It is also employed as a food supplement for adult rats to investigate the effects of dietary adenine overload. In addition to this, it is used in the production of nucleotides of the nucleic acids.

Definition

ChEBI: Adenine is the parent compound of the 6-aminopurines, composed of a purine having an amino group at C-6. It has a role as a human metabolite, a Daphnia magna metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a purine nucleobase and a member of 6-aminopurines. It derives from a hydride of a 9H-purine.

Application

Widespread throughout animal and plant tissues combined with niacinamide, d-ribose, and phosphoric acids; a constituent of nucleic acids and coenzymes, such as codehydrase I and II, adenylic acid, coa laninedehydrase. It is used in microbial determination of niacin; in research on heredity, virus diseases, and cancer.

General Description

Adenine is a purine nucleobase. It is part of DNA, and RNA. Adenine is also a component of cofactors (NAD, FAD) and signaling molecules (cAMP). It is a nitrogenous base found in DNA and RNA. It is also a constituent of certain coenzymes and when combined with the sugar ribose it forms the nucleoside adenosine found in AMP, ADP, and ATP. Adenine has a purine ring structure. It is one of the major component bases ofnucleotides and the nucleic acidsDNA and RNA.

Biochem/physiol Actions

Adenine is essential for many in vivo and in vitro biochemical processes. Adenine is converted to adenosine with ribose. On phosphorylation, it forms AMP, ADP and ATP. ATP is the energy currency of the cell and is required during cellular metabolism. Adenine is metabolized to is 2,8-dihydroxyadenine, which on accumulation in proximal tubules leads to the induction of chronic kidney disease (CKD) with severe anemia in rats. Adenine based derivatives elicit antiviral functionality against dsDNA viruses and are exploited for generating antiviral scaffolds.

Safety Profile

Poison by intraperitoneal route. Moderately toxic by ingestion. An experimental teratogen. Experimental reproductive effects. Mutation data reported. When heated to decomposition it emits toxic fumes of NOx,.

Purification Methods

Crystallise adenine from distilled water. [Beilstein 26 III/IV 3561.]

Check Digit Verification of cas no

The CAS Registry Mumber 73-24-5 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 7 and 3 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 73-24:
(4*7)+(3*3)+(2*2)+(1*4)=45
45 % 10 = 5
So 73-24-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-3H,(H2,6,7,8,9,10)

73-24-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A0149)  Adenine  >99.0%(HPLC)(T)

  • 73-24-5

  • 25g

  • 261.00CNY

  • Detail
  • TCI America

  • (A0149)  Adenine  >99.0%(HPLC)(T)

  • 73-24-5

  • 250g

  • 1,490.00CNY

  • Detail
  • Alfa Aesar

  • (A14906)  Adenine, 99%   

  • 73-24-5

  • 25g

  • 534.0CNY

  • Detail
  • Alfa Aesar

  • (A14906)  Adenine, 99%   

  • 73-24-5

  • 50g

  • 1018.0CNY

  • Detail
  • Alfa Aesar

  • (A14906)  Adenine, 99%   

  • 73-24-5

  • 250g

  • 3878.0CNY

  • Detail
  • Alfa Aesar

  • (A14906)  Adenine, 99%   

  • 73-24-5

  • 500g

  • 6293.0CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1383)  Adenine  pharmaceutical secondary standard; traceable to USP and PhEur

  • 73-24-5

  • PHR1383-1G

  • 952.15CNY

  • Detail
  • Sigma-Aldrich

  • (A0230000)  Adenine  European Pharmacopoeia (EP) Reference Standard

  • 73-24-5

  • A0230000

  • 1,880.19CNY

  • Detail
  • USP

  • (1012101)  Adenine  United States Pharmacopeia (USP) Reference Standard

  • 73-24-5

  • 1012101-200MG

  • 4,326.66CNY

  • Detail

73-24-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name adenine

1.2 Other means of identification

Product number -
Other names 7(9)H-purin-6-ylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:73-24-5 SDS

73-24-5Synthetic route

4,5,6-triaminopyrimidine
118-70-7

4,5,6-triaminopyrimidine

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
at 140 - 150℃; for 4h;81.8%
at 140 - 150℃; for 4h;81.8%
2-(methylthio)-7H-purin-6-amine
1198-83-0

2-(methylthio)-7H-purin-6-amine

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
With water; nickel
6-azidopurine

6-azidopurine

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
With water; nickel Hydrogenation;
N-(4,6-diaminopyrimidin-5-yl)formamide
5122-36-1

N-(4,6-diaminopyrimidin-5-yl)formamide

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
at 230℃;
N-(4,6-diamino-pyrimidin-5-yl)-thioformamide
409110-30-1

N-(4,6-diamino-pyrimidin-5-yl)-thioformamide

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
With water
With pyridine
With quinoline
6-amino-3,7-dihydro-purine-2-thione
3647-48-1

6-amino-3,7-dihydro-purine-2-thione

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
With water; nickel
formic acid
64-18-6

formic acid

4,5,6-triamino-pyrimidine-2-sulfinic acid
98022-70-9

4,5,6-triamino-pyrimidine-2-sulfinic acid

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

4,5,6-triaminopyrimidine sulfate
49721-45-1

4,5,6-triaminopyrimidine sulfate

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

1-methyl-4-nitrosobenzene
623-11-0

1-methyl-4-nitrosobenzene

cAMP
60-92-4

cAMP

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
at 98℃; zeitlicher Verlauf.Hydrolysis;
at 100℃; zeitlicher Verlauf.Hydrolysis;
2-amino-malonamidine; dihydrochloride
65758-94-3

2-amino-malonamidine; dihydrochloride

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
With N,N-dimethyl-formamide
With acetonitrile
glycine
56-40-6

glycine

A

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

B

guanine
73-40-5

guanine

Conditions
ConditionsYield
durch Hefe;
acetic acid
64-19-7

acetic acid

[3']adenylic acid monobenzyl ester
5957-04-0

[3']adenylic acid monobenzyl ester

A

adenosine monophosphate
84-21-9

adenosine monophosphate

B

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

acetic acid
64-19-7

acetic acid

[2']adenylic acid monobenzyl ester

[2']adenylic acid monobenzyl ester

A

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

B

adenosine 2'-monophosphate
130-49-4

adenosine 2'-monophosphate

N6,O3'-diacetyl-O5'-trityl-2'-deoxy-adenosine
911667-45-3

N6,O3'-diacetyl-O5'-trityl-2'-deoxy-adenosine

A

3'-O-acetyl-2'-deoxyadenosine
6612-73-3

3'-O-acetyl-2'-deoxyadenosine

B

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
With palladium on activated charcoal; ethanol Hydrogenation;
With ethanol; palladium Hydrogenation;
N-(7(9)H-purin-6-yl)-hydroxylamine
5667-20-9

N-(7(9)H-purin-6-yl)-hydroxylamine

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
With alkaline Na2S2O4
With palladium on activated charcoal; water Hydrogenation;
3-methyladeninium iodide

3-methyladeninium iodide

A

3-methyladenine
700-00-5

3-methyladenine

B

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

C

N-methyladenine
443-72-1

N-methyladenine

Conditions
ConditionsYield
at 270℃; for 0.25h;
1-methyladeninium iodide

1-methyladeninium iodide

A

3-methyladenine
700-00-5

3-methyladenine

B

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

C

N-methyladenine
443-72-1

N-methyladenine

Conditions
ConditionsYield
at 290℃; for 0.25h;
5'-amino-5'-deoxyadenosine p-toluenesulfonic acid salt
81090-75-7

5'-amino-5'-deoxyadenosine p-toluenesulfonic acid salt

A

(3R,4S,5R)-5-Aminomethyl-tetrahydro-furan-2,3,4-triol; hydrochloride

(3R,4S,5R)-5-Aminomethyl-tetrahydro-furan-2,3,4-triol; hydrochloride

B

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
With hydrogenchloride In water at 88℃; Rate constant;
1-<(2'S)-2',3'-dihydroxypropyl>cytosine-2'-O-phosphorylyl-(2',5')-adenosine

1-<(2'S)-2',3'-dihydroxypropyl>cytosine-2'-O-phosphorylyl-(2',5')-adenosine

A

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

B

1-<(2'S)-2',3'-dihydroxypropyl>cytosine 2',3'-cyclic monophosphate

1-<(2'S)-2',3'-dihydroxypropyl>cytosine 2',3'-cyclic monophosphate

C

1-<(2'S)-2',3'-dihydroxypropyl>cytosine 2'-monophosphate
151425-33-1

1-<(2'S)-2',3'-dihydroxypropyl>cytosine 2'-monophosphate

D

1-<(2'S)-2',3'-dihydroxypropyl>cytosine 3'-monophosphate
67770-92-7

1-<(2'S)-2',3'-dihydroxypropyl>cytosine 3'-monophosphate

E

1-<(2'S)-2',3'-dihydroxypropyl>cytosine-3'-O-phosphorylyl-(3',5')-adenosine

1-<(2'S)-2',3'-dihydroxypropyl>cytosine-3'-O-phosphorylyl-(3',5')-adenosine

F

adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With hydrogenchloride at 90.1℃; for 0.222222h; Product distribution; Rate constant;
2' 5'-dideoxyadenosine
6698-26-6

2' 5'-dideoxyadenosine

A

2-deoxy-D-ribose
36792-88-8

2-deoxy-D-ribose

B

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
With hydrogenchloride In water at 20℃; Kinetics; varying pH;
6-amino-3,7-dihydro-purine-2-thione
3647-48-1

6-amino-3,7-dihydro-purine-2-thione

sulfuric acid
7664-93-9

sulfuric acid

dihydrogen peroxide
7722-84-1

dihydrogen peroxide

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

hydrogenchloride
7647-01-0

hydrogenchloride

2',3'-isopropylidene adenosine
362-75-4

2',3'-isopropylidene adenosine

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
Kinetics; Geschwindigkeit der Hydrolyse in wss.HCl (0.1n und 1n).Hydrolysis;
hydrogenchloride
7647-01-0

hydrogenchloride

cAMP
60-92-4

cAMP

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
at 92℃; zeitlicher Verlauf.Hydrolysis;
at 100℃; zeitlicher Verlauf.Hydrolysis;
5-formylamino-1(3)H-imidazole-4-carboxamidine

5-formylamino-1(3)H-imidazole-4-carboxamidine

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
With potassium hydrogencarbonate
6-amino-2-chloro-7,9-dihydro-purin-8-one
118076-30-5

6-amino-2-chloro-7,9-dihydro-purin-8-one

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
at 140℃; anschliessend Behandeln des Reaktionsprodukts mit Jodwasserstoffsaeure und Phosphoniumjodid bei 60grad;
[5']adenylic acid monobenzyl ester
13039-55-9

[5']adenylic acid monobenzyl ester

phosphodiesterase-I

phosphodiesterase-I

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

Conditions
ConditionsYield
Phosphodiesterase-I aus Schlangengift (Crotalus adamanteus).Hydrolysis;
2,8-dichloro-7(9)H-purin-6-ylamine
2914-09-2

2,8-dichloro-7(9)H-purin-6-ylamine

hydrogen iodide
10034-85-2

hydrogen iodide

phosphonium iodide

phosphonium iodide

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

hydrogenchloride
7647-01-0

hydrogenchloride

water
7732-18-5

water

5'-Deoxy-5'-methylthioadenosine
2457-80-9

5'-Deoxy-5'-methylthioadenosine

A

S-methyl-5-thio-D-ribose
23656-67-9

S-methyl-5-thio-D-ribose

B

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

ethyl acrylate
140-88-5

ethyl acrylate

N-(9H-purin-6-yl)-β-alanine ethyl ester

N-(9H-purin-6-yl)-β-alanine ethyl ester

Conditions
ConditionsYield
With N-benzyl-trimethylammonium hydroxide In N,N-dimethyl-formamide at 110℃; for 0.5h;98%
3-hydroxy-3-methyl-1-cyano-1-butyne
32837-87-9

3-hydroxy-3-methyl-1-cyano-1-butyne

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

(Z)-3-(6-amino-9H-purin-9-yl)-4-hydroxy-4-methyl-2-pentenenitrile
1218924-50-5

(Z)-3-(6-amino-9H-purin-9-yl)-4-hydroxy-4-methyl-2-pentenenitrile

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.166667h; diastereospecific reaction;98%
3-hydroxy-3-tetramethylene-1-propynecarbonitrile
32837-90-4

3-hydroxy-3-tetramethylene-1-propynecarbonitrile

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

(Z)-3-(6-amino-9H-purin-9-yl)-3-(1-hydroxycyclopentyl)-2-propenenitrile
1218924-52-7

(Z)-3-(6-amino-9H-purin-9-yl)-3-(1-hydroxycyclopentyl)-2-propenenitrile

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.166667h; diastereospecific reaction;97%
3-(1-hydroxycyclohexyl)prop-2-ynenitrile
32837-89-1

3-(1-hydroxycyclohexyl)prop-2-ynenitrile

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

(Z)-3-(6-amino-9H-purin-9-yl)-3-(1-hydroxycyclohexyl)-2-propenenitrile
1218924-53-8

(Z)-3-(6-amino-9H-purin-9-yl)-3-(1-hydroxycyclohexyl)-2-propenenitrile

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.166667h; diastereospecific reaction;96%
3-hydroxy-3-tetramethylene-1-propynecarbonitrile
32837-90-4

3-hydroxy-3-tetramethylene-1-propynecarbonitrile

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

A

(Z)-3-(6-amino-9H-purin-9-yl)-3-(1-hydroxycyclopentyl)-2-propenenitrile
1218924-52-7

(Z)-3-(6-amino-9H-purin-9-yl)-3-(1-hydroxycyclopentyl)-2-propenenitrile

B

2,2,5,5-di(tetramethylene)-3,6-di(cyanomethylene)-1,4-dioxane
98698-56-7

2,2,5,5-di(tetramethylene)-3,6-di(cyanomethylene)-1,4-dioxane

Conditions
ConditionsYield
With triethylamine at 20℃; for 26h;A 96%
B 30%
1-(2-bromoethoxy)-2-(trifluoromethoxy)benzene

1-(2-bromoethoxy)-2-(trifluoromethoxy)benzene

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

C14H12F3N5O2

C14H12F3N5O2

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃;95.8%
4-hydroxy-4-methylhex-2-ynenitrile
32837-88-0

4-hydroxy-4-methylhex-2-ynenitrile

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

(Z)-3-(6-amino-9H-purin-9-yl)-4-hydroxy-4-methyl-2-hexenenitrile
1218924-51-6

(Z)-3-(6-amino-9H-purin-9-yl)-4-hydroxy-4-methyl-2-hexenenitrile

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.166667h; diastereospecific reaction;95%
zinc(II) acetate hexahydrate

zinc(II) acetate hexahydrate

2,6-Naphthalenedicarboxylic acid
1141-38-4

2,6-Naphthalenedicarboxylic acid

water
7732-18-5

water

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

8Zn(2+)*4C5H4N5(1-)*6C12H6O4(2-)*2HO(1-)*2H(1+)*2C2H7N*35C3H7NO*23H2O

8Zn(2+)*4C5H4N5(1-)*6C12H6O4(2-)*2HO(1-)*2H(1+)*2C2H7N*35C3H7NO*23H2O

Conditions
ConditionsYield
at 90℃; for 24h; Sealed tube;95%
7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

ethyl acrylate
140-88-5

ethyl acrylate

3-(6-aminopurine-9-yl)-propionic acid ethyl ester
7083-40-1

3-(6-aminopurine-9-yl)-propionic acid ethyl ester

Conditions
ConditionsYield
With sodium hydride In ethanol; benzene Reflux;95%
C10H10BrClO2

C10H10BrClO2

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

C15H14ClN5O2

C15H14ClN5O2

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃;94.4%
C11H12BrNO3

C11H12BrNO3

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

C16H16N6O3

C16H16N6O3

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃;94.4%
1-(5-bromo-2-(2-bromoethoxy)phenyl)ethanone
1189816-63-4

1-(5-bromo-2-(2-bromoethoxy)phenyl)ethanone

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

C15H14BrN5O2

C15H14BrN5O2

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃;94.1%
nickel(II) perchlorate hexahydrate

nickel(II) perchlorate hexahydrate

2,2',2''-triaminotriethylamine
4097-89-6

2,2',2''-triaminotriethylamine

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

[Ni(tris(2-aminoethyl)amine)(adeninato)(ClO4)]
952227-47-3

[Ni(tris(2-aminoethyl)amine)(adeninato)(ClO4)]

Conditions
ConditionsYield
With NaOH In methanol; water an aq. soln. of adenine and a MeOH soln. of N(C2H4NH2)3 and Ni salt mixed, pH adjusted to 8-9 with NaOH soln.; crystd. at room temp. for 3 wk; elem. anal.;91%
3-(1-hydroxycyclohexyl)prop-2-ynenitrile
32837-89-1

3-(1-hydroxycyclohexyl)prop-2-ynenitrile

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

A

2-amino-1-oxaspiro[4.5]dec-2-en-4-one
1218924-55-0

2-amino-1-oxaspiro[4.5]dec-2-en-4-one

B

(Z)-3-(6-amino-9H-purin-9-yl)-3-(1-hydroxycyclohexyl)-2-propenenitrile
1218924-53-8

(Z)-3-(6-amino-9H-purin-9-yl)-3-(1-hydroxycyclohexyl)-2-propenenitrile

Conditions
ConditionsYield
With lithium hydroxide In ethanol; water at 50 - 55℃; for 7h;A 8%
B 91%
acetic anhydride
108-24-7

acetic anhydride

anthranilic acid
118-92-3

anthranilic acid

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

2-methyl-3-(7H-purin-6-yl)quinazolin-4(3H)-one
1377584-88-7

2-methyl-3-(7H-purin-6-yl)quinazolin-4(3H)-one

Conditions
ConditionsYield
With titanium dioxide nanoparticles at 80℃; for 10h; Neat (no solvent);89%
[OsHCl(κ1-acetone)(CCHC19H26O)(triisopropylphosphine)2]PF6

[OsHCl(κ1-acetone)(CCHC19H26O)(triisopropylphosphine)2]PF6

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

[OsHCl(7H-amino-adenine)(CCHC19H26O)(triisopropylphosphine)2]PF6

[OsHCl(7H-amino-adenine)(CCHC19H26O)(triisopropylphosphine)2]PF6

Conditions
ConditionsYield
In acetone using Schlenk techniques; treatment of soln. of Os(P(i-Pr)3)2HCl(acetone)(CCHC17H20OMe2) in acetone with 1.1 equiv. of adenine for 15 min at room temp.; filtration through Celite; removal of solvent in vac.; dissolving in CH2Cl2; filtration through Celite; evapn. of solvent to dryness, treatment with Et2O; pptn., sepn. by decantation, washing with Et2O; drying in vac., elem. anal.;88%
[(η5-cyclopentadienyl)Ru(1,3,5-triaza-7-phosphaadamantane)(PPh3)Cl]
877864-62-5

[(η5-cyclopentadienyl)Ru(1,3,5-triaza-7-phosphaadamantane)(PPh3)Cl]

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

[RuCp(adeninate-κN9)(PPh3)(1,3,5-triaza-7-phosphaadamantane)]

[RuCp(adeninate-κN9)(PPh3)(1,3,5-triaza-7-phosphaadamantane)]

Conditions
ConditionsYield
Stage #1: 7H-purin-6-ylamine With potassium hydroxide In ethanol at 20℃; for 0.25h; Inert atmosphere; Schlenk technique;
Stage #2: [(η5-cyclopentadienyl)Ru(1,3,5-triaza-7-phosphaadamantane)(PPh3)Cl] In ethanol for 4h; Reflux; Inert atmosphere; Schlenk technique;
88%
4-hydroxy-benzaldehyde
123-08-0

4-hydroxy-benzaldehyde

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

4-((7H-purin-6-ylimino)methyl)phenol

4-((7H-purin-6-ylimino)methyl)phenol

Conditions
ConditionsYield
In ethanol for 6h; Dean-Stark; Reflux;87%
C30H35ClN3P2Ru(2+)*2CF3O3S(1-)

C30H35ClN3P2Ru(2+)*2CF3O3S(1-)

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

[RuCp(Adeninate-κN)(methyl-N-1,3,5-triaza-7-phosphaadamantane)(PPh3)](CF3SO3)

[RuCp(Adeninate-κN)(methyl-N-1,3,5-triaza-7-phosphaadamantane)(PPh3)](CF3SO3)

Conditions
ConditionsYield
Stage #1: 7H-purin-6-ylamine With potassium hydroxide In ethanol at 20℃; for 0.25h; Inert atmosphere; Schlenk technique;
Stage #2: C30H35ClN3P2Ru(2+)*2CF3O3S(1-) In ethanol at 20℃; for 4.16h; Inert atmosphere; Schlenk technique;
87%
r-2-benzyloxymethyl-c,t-1-bromo-c,t-1-bromomethyl-t-fluorocyclopropane

r-2-benzyloxymethyl-c,t-1-bromo-c,t-1-bromomethyl-t-fluorocyclopropane

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

c,t-9-{[c,t-1-bromo-t-3-fluoro-r-2-(benzyloxymethyl)cyclopropyl]methyl}adenine

c,t-9-{[c,t-1-bromo-t-3-fluoro-r-2-(benzyloxymethyl)cyclopropyl]methyl}adenine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20 - 40℃; for 10h;86%
7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

(2R,3S)-1,2-O-isopropylidene-1,2,3,4-tetrol 3,4-cyclic carbonate
609344-64-1

(2R,3S)-1,2-O-isopropylidene-1,2,3,4-tetrol 3,4-cyclic carbonate

(2'S,3'R)-9-(3',4'-O-isopropylidene-2',3',4'-trihydroxybutyl)adenine
609344-65-2

(2'S,3'R)-9-(3',4'-O-isopropylidene-2',3',4'-trihydroxybutyl)adenine

Conditions
ConditionsYield
With sodium hydroxide In N,N-dimethyl-formamide at 120℃; for 38h;85%
[Au(acac)(1,3,5-triaza-7-phosphatricyclo[3.3.1.13.7]decane)]

[Au(acac)(1,3,5-triaza-7-phosphatricyclo[3.3.1.13.7]decane)]

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

[Au(9N-adeninate)(1,3,5-triaza-7-phosphaadamantane)]

[Au(9N-adeninate)(1,3,5-triaza-7-phosphaadamantane)]

Conditions
ConditionsYield
In ethanol for 6h;85%
C10H11BrO2
1016495-38-7

C10H11BrO2

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

C15H15N5O2

C15H15N5O2

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃;84.2%
C24(13)C5H34O4SeSi
1303556-41-3

C24(13)C5H34O4SeSi

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

C27(13)C5H35N5O2SeSi
1303556-44-6

C27(13)C5H35N5O2SeSi

Conditions
ConditionsYield
Stage #1: 7H-purin-6-ylamine With ammonium sulfate; 1,1,1,3,3,3-hexamethyl-disilazane for 1.5h; Inert atmosphere; Reflux;
Stage #2: C24(13)C5H34O4SeSi With trimethylsilyl trifluoromethanesulfonate In 1,2-dichloro-ethane at -25 - 20℃; for 0.916667h; Inert atmosphere;
84%
2-thiouracil
141-90-2

2-thiouracil

4,6-dihydroxy-2-mercaptopyrimidine
504-17-6

4,6-dihydroxy-2-mercaptopyrimidine

4-nitrobenzaldehdye
555-16-8

4-nitrobenzaldehdye

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

5,7,8,9,9a,10-hexahydro-5-(4-nitrophenyl)-10-(7H-purin-6-yl)-8-thioxopyrido[2,3-d:6,5-d’]dipyrimidine-2,4,6(1H,3H,5aH)trione

5,7,8,9,9a,10-hexahydro-5-(4-nitrophenyl)-10-(7H-purin-6-yl)-8-thioxopyrido[2,3-d:6,5-d’]dipyrimidine-2,4,6(1H,3H,5aH)trione

Conditions
ConditionsYield
With phosphotungstic acid In ethanol for 6h; Reflux;84%
pyridine-4-carboxylic acid
55-22-1

pyridine-4-carboxylic acid

zinc(II) nitrate hexahydrate

zinc(II) nitrate hexahydrate

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

Zn(adeninate)(isonicotinate)(N,N'-dimethylformamide)
1309885-99-1

Zn(adeninate)(isonicotinate)(N,N'-dimethylformamide)

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 120℃; for 0.5h; Time; Temperature;83.2%
4-phenylazobenzoyl chloride
104-24-5

4-phenylazobenzoyl chloride

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

(E)-4-(phenyldiazenyl)-N-(9H-purin-6-yl)benzamide

(E)-4-(phenyldiazenyl)-N-(9H-purin-6-yl)benzamide

Conditions
ConditionsYield
With pyridine at 20 - 100℃; for 18.5h;83%
3-acetyl-8-chloro-2-phenyl-1(2H)-isoquinolinone

3-acetyl-8-chloro-2-phenyl-1(2H)-isoquinolinone

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

3-[1-(7H-purin-6-yl)iminoethyl]-8-chloro-2-phenyl-1(2H)-isoquinolinone

3-[1-(7H-purin-6-yl)iminoethyl]-8-chloro-2-phenyl-1(2H)-isoquinolinone

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene at 105 - 115℃; for 24h;82.1%
2-deoxy–α-D-ribose 1-phosphate
17039-17-7

2-deoxy–α-D-ribose 1-phosphate

7H-purin-6-ylamine
73-24-5

7H-purin-6-ylamine

2'-deoxy-D-adenosine
958-09-8

2'-deoxy-D-adenosine

Conditions
ConditionsYield
With purine nucleoside phosphorylase82%

73-24-5Relevant articles and documents

Using conformationally locked nucleosides to calibrate the anomeric effect: Implications for glycosyl bond stability

Moon, Hyung Ryong,Siddiqui, Maqbool A.,Sun, Guangyu,Filippov, Igor V.,Landsman, Nicholas A.,Lee, Yi-Chien,Adams, Kristie M.,Barchi Jr., Joseph J.,Deschamps, Jeffrey R.,Nicklaus, Marc C.,Kelley, James A.,Marquez, Victor E.

, p. 6707 - 6717 (2010)

Steric and electronic parameters, such as the anomeric effect (AE) and gauche effect play significant roles in steering the North⇆South equilibrium of nucleosides in solution. Two isomeric oxa-bicyclo[3.1.0]hexane nucleosides that are conformational

Plasmonic Hot Electron-Mediated Hydrodehalogenation Kinetics on Nanostructured Ag Electrodes

Liu, Jia,Cai, Zhuan-Yun,Sun, Wei-Xin,Wang, Jia-Zheng,Shen, Xiao-Ru,Zhan, Chao,Devasenathipathy, Rajkumar,Zhou, Jian-Zhang,Wu, De-Yin,Mao, Bing-Wei,Tian, Zhong-Qun

supporting information, p. 17489 - 17498 (2020/11/12)

An attractive field of plasmon-mediated chemical reactions (PMCRs) is developing rapidly, but there is still incomplete understanding of how to control the kinetics of such a reaction related to hot carriers. Here, we chose 8-bromoadenine (8BrAd) as a probe molecule of hot electrons to investigate the influence of the electrode potential, laser wavelength, and power on the PMCR kinetics on silver nanoparticle-modified silver electrodes. Plasmonic hot electron-mediated cleavage of the C-Br bond in 8BrAd has been investigated by combining in situ electrochemical surface-enhanced Raman spectroscopy and density functional theory calculations. The experimental and theoretical results reveal that the energy position of plasmon relaxation-generated hot electrons can be modulated conveniently by applied potentials and laser light. This allows the proposal of a mechanism of modulating the matching energy of the hot electron of plasmon relaxation to promote the efficiency of PMCRs in electrochemical interfaces. Our work will be helpful to design surface plasmon resonance photoelectrochemical reactions on metal electrode surfaces of nanostructures with higher efficiency.

Adenine intermediate pyrimidine-azo compound and preparation method thereof

-

Paragraph 0023, (2017/07/14)

The invention relates to an adenine intermediate pyrimidine-azo compound and a preparation method thereof. The preparation method comprises the following steps of: 1) dissolving primary amine in mixed-acid solution, dripping sodium nitrite solution to prepare diazonium salt shown in a formula (3), adding malononitrile for dissolving, and dripping alkaline solution to regulate a pH value of reaction solution and generate coupling reaction, thereby obtaining an intermediate pyrimidine-azo compound (4); 2) adding the intermediate pyrimidine-azo compound (4) prepared in the step 1) into formamide, introducing liquid ammonia, and heating to carry out high-temperature condensation and cyclization reaction, thereby obtaining an adenine intermediate pyrimidine-azo compound (5), wherein a series of derivatives of the adenine intermediate pyrimidine-azo compound can be prepared by selecting different primary amines. The adenine intermediate pyrimidine-azo compound and the preparation method have the advantages that water is used as a solvent in the step 1), and the solvent used in the step 2) can be repeatedly used, so that the 'three wastes' are fewer, and the environment-friendly effect is achieved; and the cost is low, so that the industrialization is easy and the economic benefit is obvious.

Biosynthesis of 4-aminoheptose 2-epimers, core structural components of the septacidins and spicamycins

Price, Neil P.J.,Furukawa, Takayuki,Cheng, Fang,Qi, Jianzhao,Chen, Wenqing,Crich, David

, p. 405 - 414 (2014/06/10)

Septacidins and spicamycins are acylated 4-aminoheptosyl-β-N- glycosides produced by Streptomyces fimbriatus and S. alanosinicus, respectively. Their structures are highly conserved, but differ in the stereochemistry of the 4-aminoheptosyl residues. The o

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 73-24-5